Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison C Nugent

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Journal of Clinical Psychopharmacology|March 31, 2018
Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to IntolerabilityBashkim Kadriu, Shiwen Yuan, Cristan Farmer, et al.
Biological Psychiatry|November 25, 2010
Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging studyJonathan B Savitz, Allison C Nugent, Wendy Bogers, et al.
Neuroscience and Biobehavioral Reviews|May 2, 2024
Exploring the impact of music on response to ketamine/esketamine: A scoping reviewMina Kheirkhah, Allison C Nugent, Alicia A Livinski, et al.
Neuroimage|November 26, 2009
Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medicationJonathan Savitz, Allison C Nugent, Wendy Bogers, et al.
Bipolar Disorders|March 17, 2012
Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studiesSudhakar Selvaraj, Danilo Arnone, Dominic Job, et al.
Journal of Psychopharmacology (Oxford, England)|October 18, 2017
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorderMark J Niciu, Nicolas D Iadarola, Dipavo Banerjee, et al.
Nutrients|October 26, 2024
A Pilot Randomized Control Trial Testing a Smartphone-Delivered Food Attention Retraining Program in Adolescent Girls with Overweight or ObesityMegan N Parker, Bess F Bloomer, Jeffrey D Stout, et al.
Scientific Data|August 25, 2022
The NIMH intramural healthy volunteer dataset: A comprehensive MEG, MRI, and behavioral resourceAllison C Nugent, Adam G Thomas, Margaret Mahoney, et al.
Frontiers in Psychiatry|September 18, 2025
Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trialMina Kheirkhah, Nastasia McDonald, Julia Aepfelbacher, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Journal of Clinical Psychopharmacology|March 31, 2018
Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to IntolerabilityBashkim Kadriu, Shiwen Yuan, Cristan Farmer, et al.
Biological Psychiatry|November 25, 2010
Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging studyJonathan B Savitz, Allison C Nugent, Wendy Bogers, et al.
Neuroscience and Biobehavioral Reviews|May 2, 2024
Exploring the impact of music on response to ketamine/esketamine: A scoping reviewMina Kheirkhah, Allison C Nugent, Alicia A Livinski, et al.
Neuroimage|November 26, 2009
Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medicationJonathan Savitz, Allison C Nugent, Wendy Bogers, et al.
Bipolar Disorders|March 17, 2012
Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studiesSudhakar Selvaraj, Danilo Arnone, Dominic Job, et al.
Journal of Psychopharmacology (Oxford, England)|October 18, 2017
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorderMark J Niciu, Nicolas D Iadarola, Dipavo Banerjee, et al.
Nutrients|October 26, 2024
A Pilot Randomized Control Trial Testing a Smartphone-Delivered Food Attention Retraining Program in Adolescent Girls with Overweight or ObesityMegan N Parker, Bess F Bloomer, Jeffrey D Stout, et al.
Scientific Data|August 25, 2022
The NIMH intramural healthy volunteer dataset: A comprehensive MEG, MRI, and behavioral resourceAllison C Nugent, Adam G Thomas, Margaret Mahoney, et al.
Frontiers in Psychiatry|September 18, 2025
Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trialMina Kheirkhah, Nastasia McDonald, Julia Aepfelbacher, et al.
Pageof 10